Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
08/2000
08/17/2000WO2000015231A9 Adenosine a3 receptor modulators
08/17/2000WO2000014230A9 Novel molecules of the herpes virus-entry-mediator-related protein family and uses thereof
08/17/2000WO2000005393A3 A polynucleotide comprising a ubiquitous chromatin opening element (ucoe)
08/17/2000DE19956568A1 Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens Method and medicament for the inhibition of expression of a given gene
08/17/2000DE19906290A1 Orally administered medicament for treating colon cancer comprises ursodesoxycholic acid in gastric fluid resistant coating to provide direct topical action at target site
08/17/2000DE19906096A1 Protein mit einem Heparin-bindenden Epitop Protein having a heparin-binding epitope
08/17/2000DE19905883A1 Chimäre Virus-ähnliche Partikel bzw. chimäre Capsomere von BPV Chimeric virus-like particles or chimeric capsomeres of BPV
08/17/2000DE19905501A1 Verfahren zur Herstellung eines rekombinanten Adeno-assoziierten Virus, geeignete Mittel hierzu sowie Verwendung zur Herstellung eines Arzneimittels A method of producing a recombinant adeno-associated virus, as well as suitable means to this end use for the preparation of a medicament
08/17/2000CA2366487A1 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
08/17/2000CA2362707A1 Means for regulating hematopoietic differentiation
08/17/2000CA2362592A1 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith
08/17/2000CA2362578A1 Tumor vaccines
08/17/2000CA2362560A1 Controlling protein levels in eucaryotic organisms
08/17/2000CA2362523A1 Nitroreductase enzymes
08/17/2000CA2362464A1 A synthetic peptide disturbing intracellular signaling
08/17/2000CA2362426A1 Anticancer drug enhancer
08/17/2000CA2362390A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors
08/17/2000CA2362377A1 Maturation of dendritic cells with immune response modifying compounds
08/17/2000CA2362373A1 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
08/17/2000CA2362372A1 Tyrosine alkoxyguanidines as integrin inhibitors
08/17/2000CA2362295A1 Polynucleotide encoding multimers of antigenic peptides in order to enhance presentation of the antigenic peptide by mhc molecules
08/17/2000CA2362272A1 Spirocyclic ketones and their use as tachykinin antagonists
08/17/2000CA2362109A1 Novel antisense inhibition of rad51
08/17/2000CA2361334A1 Deglycosylated kringle 1-3 region fragments of plasminogen and methods of use
08/17/2000CA2361293A1 33 human secreted proteins
08/17/2000CA2360952A1 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
08/17/2000CA2360123A1 Encapsulated cells containing an amplified expression vector as a drug delivery device
08/17/2000CA2359748A1 Method of producing a recombinant adeno-associated virus, suitable means for producing the same and use thereof for producing a medicament
08/17/2000CA2359660A1 16-hydroxyestratrienes as selective estrogens
08/16/2000EP1028117A2 Novel protein: prenyl transferase inhibitors
08/16/2000EP1028114A1 Novel guanidine derivatives as inhibitors of cell adhesion
08/16/2000EP1027893A2 Alginate containing medicament and implant for treating fibrosis
08/16/2000EP1027892A2 Azithromycin combination for emesis control in dogs
08/16/2000EP1027890A2 Homer a new target of treating psychiatric disorders
08/16/2000EP1027887A2 Matrix controlled release device
08/16/2000EP1027444A1 Reagents and methods useful for detecting diseases of the breast
08/16/2000EP1027443A2 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor
08/16/2000EP1027440A1 Inhibitor protein of the wnt signal pathway
08/16/2000EP1027438A2 Novel cytokine receptors
08/16/2000EP1027437A1 Wnt-1 induced secreted polypeptides: wisp-1, -2 and -3
08/16/2000EP1027431A2 April- a novel protein with growth effects
08/16/2000EP1027375A1 Anti-idiotypic monoclonal antibodies, their use in the active immunotherapy of malignant tumors, and compositions containing them
08/16/2000EP1027365A2 Antitumour uridine analogues
08/16/2000EP1027359A2 Monocyclic l-nucleosides, analogs and uses thereof
08/16/2000EP1027354A1 Phthalocyanine analogs
08/16/2000EP1027345A1 Synthetic methods for polyphenols
08/16/2000EP1027338A2 New carboxylic acid derivatives, carrying amido side-chains; production and use as endothelin receptor antagonists
08/16/2000EP1027337A1 Integrin receptor antagonists
08/16/2000EP1027332A1 Novel lactam metalloprotease inhibitors
08/16/2000EP1027330A1 Styryl sulfone anticancer agents
08/16/2000EP1027060A2 Use of macrolides for the treatment of cancer and macular degeneration
08/16/2000EP1027056A1 Alpha-ketoamide multicatalytic protease inhibitors
08/16/2000EP1027046A1 Antagonists of gonadotropin releasing hormone
08/16/2000EP1027045A1 Methods and compositions for regulation of 5-alpha reductase activity
08/16/2000EP1027042A1 Inhibitors of farnesyl protein transferase
08/16/2000EP1027036A2 Taste masked formulations
08/16/2000EP0934325A4 Tetraphosphonate bicyclic trisanhydrides
08/16/2000EP0753015B1 Monoclonal antibodies recognizing tie-receptor and their use
08/16/2000EP0690711B1 Taxanes having an amino substituted side-chain
08/16/2000CN1263560A Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in sample of normal cells
08/16/2000CN1263535A LH-RH peptide analogues, their uses and pharmaceutical compositions containing them
08/16/2000CN1263532A 13-dihydro-3' aziridino anthracyclines
08/16/2000CN1263474A Use of intravenous contrast agents and device for projection mammography
08/16/2000CN1263471A Pharmaceutical composition having enhanced antitumor activity and/or reduced side effects, containing antitumor agent and hydroxamic acid derivative
08/16/2000CN1263466A Solutions containing azasteroids
08/16/2000CN1263461A Pharmaceutical composition
08/16/2000CN1263449A Device for projection mammography
08/16/2000CN1263095A New tricycloacylamide compound, its preparation method and medicinal composition containing them
08/16/2000CN1262955A Chinese medicine powder preparation for curing leukemia
08/16/2000CN1262925A Preparation method of microlipid granule for wrapping medicine
08/16/2000CN1055480C Substitution analogues of magainin peptides
08/16/2000CN1055467C Taxoids compound, their preparation and pharmaceutical compositions containing them
08/15/2000US6103936 Reacting aldehyde, sulfide, sulfone, or sulfoxide with formamide in presence of acid catalyst, and optionally a dehydrating agent
08/15/2000US6103877 Purified antibody which specifically binds to human hypermethylated in cancer-1 polypeptide of specific amino acid sequence or its immunoreactive fragments; for diagnosis/ prognosis of cell proliferative disorders such as cancer
08/15/2000US6103762 A biaromatic compounds in which the aromatic nuclei are connected by a propynylene or allenylene divalent radical, useful as human or veterinary medicine or used in cosmetics or keratinization disorders
08/15/2000US6103739 Metalloproteinase inhibitors
08/15/2000US6103728 Modulating tyrosine signal transduction to prevent and treat cell proliferative disorders or cell differentiation disorders by inhibiting one or more abnormal tyrosine kinase activities; anticarcinogenic,-tumor, proliferative agents
08/15/2000US6103727 Pyrimidine derivatives and methods of making and using these derivatives
08/15/2000US6103720 Ketobenzamides as calpain inhibitors
08/15/2000US6103705 Pharmaceutical composition comprising a compound having anti-Xa activity and a platelet aggregation antagonist compound
08/15/2000US6103698 Useful in treating cancer in a mammal; in combination with paclitaxel and taxotere
08/15/2000US6103692 Administering to said mammal, or contacting said cells with, a compound which inhibits lipid-dependent direct binding of a non-effector loop domain of ras with a raf zinc finger domain
08/15/2000US6103527 Nucleotide sequence from gene expressed in proliferating endothelial cells; for controlled gene expression especially for transgenic tissues and gene therapy
08/15/2000US6103513 Novel proteolytic enzyme; for the treatment of immune, proliferative and degratory defects
08/15/2000US6103237 More stable to purification than wild type mature hk2 polypeptide.
08/15/2000US6102254 Pharmaceutical compositions in semisolid form and a device for administration thereof
08/15/2000CA2202280C Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/15/2000CA2153391C Inducing cytotoxic t lymphocyte responses
08/15/2000CA2142861C Novel uses of il-4 and/or il-10, and antibodies against the same
08/15/2000CA2034484C Radioimmunotherapy using .alpha.-particles emission
08/15/2000CA1341083C Purified recombinant interleukin-2 and process for recovering and purifying same
08/10/2000WO2000046391A2 Genes displaying enhanced expression during cellular senescence and terminal cell differentiation and uses thereof
08/10/2000WO2000046367A2 Proteins capable of triggering g2/m transition and of interacting with cdc2- and cyclin b
08/10/2000WO2000046352A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000WO2000046253A1 Process for the production of multiple cross-linked hyaluronic acid derivatives
08/10/2000WO2000046251A2 Human polyclonal antibodies from transgenic nonhuman animals
08/10/2000WO2000046248A1 Use of agonists or antagonists of mip-3a in therapy
08/10/2000WO2000046240A2 Polypeptides involved in immune response
08/10/2000WO2000046235A1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
1 ... 1889 1890 1891 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 ... 2211